Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Repligen Cp
(NQ:
RGEN
)
187.33
USD
-14.66 (-7.26%)
Official Closing Price
Updated: 7:57 PM EST, Jan 27, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Repligen Cp
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Noteworthy Tuesday Option Activity: SIX, RGEN, CEVA
January 26, 2021
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Six Flags Entertainment Corp (SIX), where a total volume of 6,001 contracts has...
Tags
Stocks
From
Market News Video
Dow Jones, S&P 500 Up Slightly After Giving Up Gains; Microsoft In Buy Zones Ahead Of Earnings
January 26, 2021
The Dow Jones Industrial Average traded around breakeven in today's stock market, while the S&P 500 edged up from earlier highs of the day.
From
Investor's Business Daily
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
January 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ACRS
ALGS
NDRA
From
Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
GRCL
GRTS
BAYRY
From
Benzinga
Repligen In Buy Zone
January 15, 2021
Repligen is in a buy zone following two weeks of strong gains. RS line picking up.
From
Investor's Business Daily
Stock Market Analysis: Nasdaq Pullback Healthy; SolarEdge, Yatsen IPO Dive, Repligen In Buy Zone
January 15, 2021
Stock market analysis: Nasdaq pullback healthy; SolarEdge, Yatsen IPO dive, Repligen in buy zone.
From
Investor's Business Daily
Shopify: One Of Two Sector Leader Stocks Still In Potential Buy Range
January 15, 2021
Shopify stock is one of six Sector Leaders still in potential buy range as key market indexes slip from record highs. Who else finished in buy zone?
From
Investor's Business Daily
IBD 50: A Strong Week For Growth Stocks, Small Caps, With A Few Warning Signs
January 15, 2021
Repligen and Generac were two of the IBD 50 growth stocks that ended the week in buy ranges. But a number of other breakouts flashed some warnings signs.
From
Investor's Business Daily
Why This IBD Stock Of The Day Is On A Run As Covid Vaccine Demand Surges
January 15, 2021
Repligen is the IBD Stock Of The Day. Shares of RGEN stock are lingering in a chase zone after busting out of a cup base on Thursday. The company is a leader in bioprocessing.
From
Investor's Business Daily
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SYNH
TXG
APDN
From
Benzinga
Dow Jones Fades As Market Watches Biden's $2 Trillion Stimulus Plan; Jobless Claims Disappoint
January 14, 2021
The Dow Jones traded modestly higher in today's stock market as the blue chip index and the Nasdaq composite faded from earlier gains.
From
Investor's Business Daily
Stocks That Hit 52-Week Highs On Thursday
January 14, 2021
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs. Noteworthy Points: Taiwan Semiconductor ...
Tags
SNEX
WSC
WIT
From
Benzinga
Dow Jones Rises As Stock Market Shrugs Off Trump Impeachment, Jobs Data
January 14, 2021
The Dow Jones Industrial Average rallied more than 100 points midday Thursday, despite sharply higher jobless data and President Trump's impeachment.
From
Investor's Business Daily
Learning From Stock Market Losers
January 14, 2021
Rule Breaker Investing: David's Biggest Losers Volume 6
Tags
TRVG
IQ
MDB
From
Motley Fool
Here's Why You Should Really Own Repligen in 2021
January 13, 2021
The tailwinds behind the company's gains aren't going anywhere.
Tags
Market News
RGEN
From
Motley Fool
Apple Stock, Chipotle Headline 5 Top Stocks Flashing Buy Signals
January 09, 2021
Five top stocks flashing buy signals include Apple, Chinese internet giant Tencent and fast-casual Mexican chain Chipotle Mexican Grill.
From
Investor's Business Daily
Dow Jones Turns Lower On Senator Manchin Comment While Nasdaq Leads, Hits New High
January 08, 2021
The Dow Jones Industrial Average traded slightly lower in today's stock market after the major indexes all hit fresh record highs the day prior.
From
Investor's Business Daily
Spotify Stock, Repligen Still Act Well, But Share This Risk
January 08, 2021
There is a significant risk with Shopify stock: The latest base was a late-stage pattern.
From
Investor's Business Daily
Noteworthy ETF Inflows: PTH, AMED, RGEN, TGTX
January 05, 2021
Symbols mentioned in this story: PTH, AMED, RGEN, TGTX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
January 04, 2021
From
GlobeNewswire News Releases
Why Repligen Stock Soared 107% in 2020
January 01, 2021
The bioprocessing technology company gained momentum during the coronavirus pandemic.
Tags
Market News
RGEN
DHR
From
Motley Fool
This Coronavirus Vaccine Play Up 107% In 2020 Eyes New Buy Point Amid Consolidation
December 31, 2020
Repligen is this week's stock to watch from the IBD Sector Leaders screen as it eyes a new buy point.
From
Investor's Business Daily
P/E Ratio Insights for Repligen
December 30, 2020
In the current session,Repligen Inc. (NASDAQ: RGEN)is trading at $192.31, after a1.74%increase. Over ...
Tags
Earnings
Benzinga
RGEN
From
Benzinga
Seven Top Growth Stocks With Wild 2020 Gains, 2 Are Near Buy Points
December 24, 2020
PennyMac Financial Services and Repligen were top growth stocks near buy points on IBD's exclusive Sector Leaders list this week.
From
Investor's Business Daily
This Pharma Stock Up 146% Offers Opportunity After Making Bullish Move
December 18, 2020
Pharma stock Repligen is this week's stock to watch from the IBD Sector Leaders screen. The stock, up 146% on 2020 lows, is offering a buying opportunity.
From
Investor's Business Daily
Megatrends To Invest In Now: 3 Best ETF Picks
December 16, 2020
BlackRock has identified five big trends that are here to stay for the long haul. Investors can get exposure to these drivers via 17 iShares ETFs.
From
Investor's Business Daily
Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters’ Option
December 10, 2020
From
GlobeNewswire News Releases
EC Mergers & Acquisitions advised ARTeSYN on its Sale to Repligen
December 08, 2020
EC Mergers & Acquisitions ("EC M&A") is pleased to confirm the sale of ARTeSYN BioSolutions ("ARTeSYN")
From
PR Newswire
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
STRO
Penny Stocks
CDNA
From
Benzinga
Repligen Corporation Prices Public Offering of Shares of Common Stock
December 07, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.